Characteristic | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
n | OR (95% CI) | p value | n | OR (95% CI) | p value | |
Hypotension | 164 | Â | Â | 153 | Â | Â |
 Yes |  | 8.42 (3.47–20.39) | <0.001 |  | 3.56 (1.05–12.09) | 0.042 |
 No |  | 1.00 (Reference) |  |  | 1.00 (Reference) |  |
WBC (cells/μL) | 163 |  |  |  |  |  |
  > 10 × 103 |  | 4.95 (2.22–11.02) | <0.001 |  |  |  |
  ≤ 10 × 103 |  | 1.00 (Reference) |  |  |  |  |
Overt DIC | 164 | Â | Â | Â | Â | Â |
 Yes |  | 3.39 (1.76–6.55) | <0.001 |  |  |  |
 No |  | 1.00 (Reference) |  |  |  |  |
Capillary leakage | 164 | Â | Â | Â | Â | Â |
 Yes |  | 9.36 (2.09–42.00) | 0.003 |  |  |  |
 No |  | 1.00 (Reference) |  |  |  |  |
Creatine kinase (IU/L) | 164 | Â | Â | 153 | Â | Â |
  > 500 |  | 10.81 (5.05–23.12) | <0.001 |  | 6.24 (2.10–18.49) | 0.001 |
  ≤ 500 |  | 1.00 (Reference) |  |  | 1.00 (Reference) |  |
Blood sugar (mg/dL) | 164 | Â | Â | Â | Â | Â |
  ≥ 150 |  | 2.79 (1.27–6.10) | 0.010 |  |  |  |
  < 150 |  | 1.00 (Reference) |  |  |  |  |
Serum sodium (mmol/L) | 164 | Â | Â | 153 | Â | Â |
  < 135 mmol/L |  | 9.46 (4.60–19.43) | <0.001 |  | 7.81 (2.87–21.24) | <0.001 |
  ≥ 135 mmol/L |  | 1.00 (Reference) |  |  | 1.00 (Reference) |  |
Microscopic hematuria | 162 | Â | Â | 153 | Â | Â |
 Yes |  | 10.51 (4.74–23.28) | <0.001 |  | 11.45 (3.76–34.82) | <0.001 |
 No |  | 1.00 (Reference) |  |  | 1.00 (Reference) |  |
Time from bite to receiving antivenom (hours) | 156 | Â | Â | 153 | Â | Â |
  ≥ 2 |  | 2.45 (1.20–5.02) | 0.014 |  | 7.98 (2.06–30.92) | 0.003 |
  < 2 |  | 1.00 (Reference) |  |  | 1.00 (Reference) |  |